References
Stary, H. C. Pathologie der Atherosklerose. In:Schwand, P., Richter, E. (eds.): Handbuch der Fettstoffwechselstörungen. Schattauer-Verlag, Stuttgart 1995, pp. 48–64.
Fuster, V., Badimon, L., Badimon, J., Chesebro, J. H. The pathogenesis of coronary artery disease and the acute coronary syndromes. N. Engl. J. Med. 326 (1992) 242–250.
Klurfeld, D. M. Identification of foam cells in human atherosclerotic lesions as macrophages using monoclonal antibodies. Arch. Pathol. Lab. Med. 109 (1985) 445–449.
Benditt, E. P., Benditt, J. M. Evidence for a monoclonal origin of human atherosclerotic plaques. Proc. Natl. Acad. Sci. USA 70 (1973) 1753–1759.
Ross, R. The pathogenesis of atherosclerosis: a perspective of the 1990s. Nature 362 (1993) 801–809.
Saikku, P., Wang, S. O., Kleemola, M., Brander, E., Rusanen, E., Grayston, J. T. An epidemic of mild pneumonia due to an unusual strain ofChlamydia psittaci. J. Infect. Dis. 151 (1985) 832–839.
Grayston, J. T., Kuo, C. C., Wang, S. P., Altmann, J. A newChlamydia psittaci strain, TWAR, isolated in acute respiratory tract infection. N. Engl. J. Med. 315 (1986) 161–168.
Allegra, L., Blasi, F. Chlamydia pneumoniae infection. Springer Verlag, Milano 1995.
Cook, P. J., Honeybourne, D. Chlamydia pneumoniae. J. Antimicrob. Chemother. 34 (1994) 859–873.
Grayston, J. T., Kuo, C. C., Campbell, L. A., Wang, S. P. Proposal to create theChlamydia pneumoniae sp. nov. forChlamydia TWAR. Intern. J. System. Bacteriol. 39 (1989) 88–90.
Forsey, T., Darouger, S., Treharne, J. D., Jones, B. R., Herring, A. J. Prevalence in human beings of antibodies toChlamydia. IOL-207, an atypical strain ofChlamydia. J. Infect. 12 (1986) 145–152.
Saikku P.: Chlamydia TWAR and its epidemiology. In: Proceedings of the First Conference of the European Society for Chlamydial Research. Stockholm, Almquist & Wiksell International 1988, pp. 7–10.
Saikku, P. The epidemiology and significance ofChlamydia pneumoniae. J. Infect. 25 (Suppl. 1) (1992) 27–34.
Saikku, P., Mattila, K., Nieminen, M. S., Huttunen, J. K., Leinonen, M., Ekmann, M.-R., Mäkelä, P. H., Valtonen, V. Serological evidence of an association of a novelChlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet ii (1988) 983–984.
Linnanmäki, E., Leinonen, M., Mattila, K., Nieminen, M. S., Valtonen, V., Saikku, P. Chlamydia pneumoniae-specific circulating immune complexes in patients with chronic coronary heart disease. Circulation 87 (1993) 1130–1134.
Saikku, P., Leinonen, M., Linnanmöki, E., Mattila, K., Nieminen, M. S., Valtonen, V. Association of immune complexes containing chlamydial lipopolysaccharide with coronary heart disease. In:Bowie, W. R., Caldwell, H. D., Jones, R. P., Mårdh, P.-A., Ridgway, G. I., Schachter, J. (eds.): Chlamydial infections. Cambridge University Press, Cambridge 1990, pp. 449–452.
Dahlen, G. H., Boman, J., Birgander, L. S., Lindblom, B. Lp(a) lipoprotein, IgG, IgA and IgM antibodies toChlamydia pneumoniae and HLA Class II genotype in early coronary artery disease. Atherosclerosis 114 (1995) 165–174.
Gounaris, T. H., Sioula, E., Anagnostopoulou, M., Spirou, P., Zouroudis, M., Kouskos, G., Flessas, L., Pniara, O., Saroglou, G.: Chlamydia pneumoniae (CP) antibodies in patients with acute myocardial infarction (AMI). 35th ICAAC 17–20 Sept. 1995, San Francisco, abstr. LM75.
Grayston, J. T., Kuo, C. C., Campbell, L. A., Benditt, E. P. Chlamydia pneumoniae, strain TWAR and atherosclerosis. Eur. Heart J. 14 (Suppl. K) (1993) 66–71.
Grayston, J. T., Kuo, C. C., Coulson, A. S., Campbell, L. A., Lawrence, R. D., Lee, M. J., Strandness, E. D., Wang, S. P. Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery. Circulation 92 (1995) 3397–3400.
Hahn, D. L., Saikku, P. Chlamydia, smoking and heart disease. Ann. Int. Med. 117 (1992) 71.
Hahn, D. L., Golubjanikow, R. Smoking is a potential confounder of theChlamydia pneumoniae-coronary artery disease association. Arterioscler. Thromb. 12 (1992) 945–947.
Maass, M., Gieffers, J. Prominent serological response toChlamydia pneumoniae in cardiovascular disease. Immunol. Infect. Dis. 6 (1996) 65–70.
Maass, M.: Chlamydia pneumoniae in der Ätiologie respiratorischer und vaskulärer Erkrankungen des Menschen. Habilitationsschrift Lübeck 1996.
MeInick, S. L., Shahar, E., Folsom, A. R., Grayson, J. T. Sorlie, P. D. Wang, S. P., Szklo, M. Past infection byChlamydia pneumoniae strains TWAR and asymptomatic carotid atherosclerosis. Am. J. Med. 95 (1993) 439–445.
Mendall, M. A., Carrington, D., Strachan, D., Patel, P., Molineaux, N., Levi, J., Toosey, T., Camm, A. J., Northfield, T. C. Chlamydia pneumoniae risk factors for seropositivity and association with coronary heart disease. J. Infect. 30 (1995) 121–128.
Paltiel, O., Kark, J. D., Leinonnen, M., Sikku, P. High prevalence of antibodies toChlamydia pneumoniae; determinants of IgG and IgA seropositivity among Jerusalem residents. Epidemiol. Infect. 114 (1995) 465–473.
Sutter, M. C. Lessons for atherosclerosis research from tuberculosis and peptic ulcer. Can. Med. Assoc. J. 152 (1995) 667–670.
Thom, D. H., Wang, S. P., Steward, D. K., Grayston, J. T. Chlamydia pneumoniae strain TWAR antibody and angiographically demonstrated coronary artery disease. In:Bowie, W. R., Caldwell, H. D., Jones, R. P., Mårdh, P.-A., Ridgway, G. L., Schachter, J. (eds.): Chlamydial infections. Cambridge University Press, Cambridge 1990, pp. 453–456.
Miettinen, H., Lehto, S., Saikku, P., Haffner, S. M., Rönnemaa, T., Pyörälä, K., Laasko, M. Association ofChlamydia pneumoniae and acute coronary heart disease events in non-insulin dependent diabetic and non-diabetic subjects in Finland. Eur. Heart J. 17 (1996) 682–688.
Puolakkainen M., Kuo, C. C., Shor, A., Wang, S. P., Grayston, J. T., Campbell, L. A. Serological response toChlamydia pneumoniae in adults with coronary arterial fatty streaks and fibrolipid plaques. J. Clin. Microbiol. 31 (1993) 2212–2214.
Thom, D. H., Grayston, J. T., Siscovick, D. S., Wang, S.-P., Weiss, N. S., Daling, J. R. Association of prior infection withChlamydia pneumoniae and angiographically demonstrated coronary artery disease. JAMA 268 (1992) 68–72.
Kuo, C. C., Shor, A., Campbell, L. A., Fuhushi, H., Patton, D. L., Grayston, J. T. Demonstration ofChlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J. Infect. Dis. 167 (1993) 841–849.
Shor, A., Kuo, C. C., Patton, D. L. Detection ofChlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaque. S. Afr. Med. J. 82 (1992) 158–161.
Blasi, F., Denti, F., Erba, M., Cosentini, R., Raccanelli, R., Rinaldi, A., Fagetti, L., Esposito, G., Ruberti, U., Allegra, L. Detection ofChlamydia pneumoniae but notHelicobacter pylori in atherosclerotic plaques of aortic aneurysms. J. Clin. Microbiol. 34 (1996) 2766–2769.
Campbell, L. A., O'Brien, E. R., Cappuccio, A. L., Kuo, C. C., Wang, S. P., Stewart, D., Patton, D. L., Cummings, P. K., Grayston, J. T. Detection ofChlamydia pneumoniae TWAR in human coronary atherectomy tissues. J. Infect. Dis. 172 (1995) 585–588.
Enzler, M. J., Smith, T. F., Espy, M., Felmlee, T., Rumberger, J., Rous, M. S., Edwards, W. D., Steckelberg, J.: Inability to detectChlamydia pneumoniae (TWAR) in human autopsy coronary arteries (CA) by polymerase chain reaction (PCR). 35th ICAAC 17–20 Sept. 1995, San Francisco, abstr. LM81.
Muhlestein, J. B., Hammond, E. H., Carlquist, J. F., Radicke, E., Thomson, M. J., Karagounis, L. A., Woods, M. L., Anderson, J. L. Increased incidence ofChlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease. J. Am. Coll. Cardiol. 27 (1996) 1555–1561.
Ong, G., Thomas, B. J., Mansfield, A. O., Davidson, B. R., Taylor-Robinson, D. Detection and widespread distribution ofChlamydia pneumoniae in the vascular system and its possible implications. J. Clin. Pathol. 49 (1996) 102–106.
Ramirez, J. A. and theChlamydia pneumoniae/Atherosclerosis Study Group: Isolation ofChlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. Ann. Intern. Med. 125 (1996) 979–982.
Weiss, S. M., Boblin, P. M., Gaydos, C. A., Cumming, P., Patton, D. L., Schulhoff, N., Shani, J., Frankel, R., Penney, K., Quinn, T. C., Hammerschlag, M. R. Failure to detectChlamydia pneumoniae in coronary atheromas of patients undergoing atherectomy. J. Infect. Dis. 173 (1996) 957–962.
Ouchi, K., Fujii, B., Kanamoto, Y., Miyazaki, H., Nakazawa, T.: Detection ofChlamydia pneumoniae in atherosclerotic lesions of coronary arteries and large arteries. 35th ICAAC 17–20 Sept. 1995, San Francisco, abstr. K37.
Kuo, C. C., Grayston, J. T., Campbell, L. A., Goo, Y. A., Wissler, R. W., Benditt, E. P. Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15–34 years old). Proc. Natl. Acad. Sci. USA 92 (1995) 6911–6914.
Wesslén, L., Pahlson, C., Lindquist, O., Hjelm, E., Gnarpe, J., Larsson, L. E., Baandrup, U., Eriksson, L., Fohlman, J., Engstrand, L., Linglöf, T., Nyström-Rosander, C., Gnarpes, H., Magnius, L., Rolf, C., Friman, G. An increase in sudden unexpected cardiac deaths among young Swedish orienteers during 1979–1992. Eur. Heart J. 17 (1996) 902–910.
Liuzzo, G., Biasucci, L. M., Gallimore, J. R., Grillo, R. L., Rebuzzi, A. G., Pepys, M. B., Maseri, A. The prognostic value of C-reactive protein and serum amyloid, a protein in severe unstable angina. N. Engl. J. Med. 331 (1994) 412–424.
Kuller, L. H., Tracy, R. P., Shaten, J., Meilan, E. N. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control-study. Am. J. Epidemiol. 144 (1996) 537–547.
Yarnell, J. W. G., Baker, I. A., Sweetnam, P. M., Bainton, D., O'Brien, J. R., Whitehead, P. J., Elwood, P. C. Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell Heart Disease Studies. Circulation 83 (1991) 836–844.
Zalokar, J. B., Richard, J. L., Claude, J. R. Leukocyte count, smoking, and myocardial infarction. N. Engl. J. Med. 304 (1981) 465–468.
Friedmann, G. D., Klatsky, A. L., Siegelaub, A. B. The leukocyte count as a predictor of myocardial infarction. N. Engl. J. Med. 290 (1974) 1275–1278.
Grimm, R. H., Neaton, J. D., Ludwig, W., forthe Multiple Risk Factor Intervention Trial Group Prognostic importance of the white blood cell count for coronary, cancer, and all-cause mortality. JAMA 254 (1985) 1932–1937.
Patel, P., Carrington, D., Strachan, D. P., Leatham, E., Goggin, P., Northfield, T. C., Mendall, M. A. Fibrinogen: a link between chronic infection and coronary heart disease. Lancet 343 (1994) 1634–1635.
Meade, T. W. Fibrinogen and cardiovascular disease. J. Clin. Pathol. 50 (1997) 13–15.
Gaydos, C. A., Summersgill, J. T., Sahney, N. N., Ramirez, J. A., Quinn, T. C. Replication ofChlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells. Infection Immun. 64 (1996) 1614–1620.
Godzik, K. L., O'Brien, E. R., Wang, S. K., Kluo, C. C. In vitro susceptibility of human vascular wall cells to infection withChlamydia pneumoniae. J. Clin. Microbiol. 33 (1995) 2411–2414.
Fong, I. W., Chiu, B., Viira, E., Fong, M., Jang, D., Mahony, J. Rabbit model forChlamydia pneumoniae infection. J. Clin. Microbiol. 35 (1997) 48–52.
Gupta, S., Leatham, E. W., Carrington, D., Mendall, M., Kaski, J. C., Camm, A. J. ElevatedChlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction. Circulation 96 (1997) 404–407.
Stille, W., Just-Nübling, G. Argumente für eine Antibiotika-Therapie der Arteriosklerose. Chemotherapie Journal 6 (1997) 1–5.
Gurfinkel, E., Bozovich, G., Daroca, A., Beck, E., Mautner, B., for the Roxis Study Group: Randomised trial of roxithromycin in non Q-wave coronary syndromes: ROXIS pilot study. Lancet (1997) 404–407.
Ward, M. E. The immunobiology and immunopathology of chlamydial infection. APMIS 103 (1995) 769–796.
Moazed, T. C., Kuo, C. C., Grayston, J. T., Campbell, L. A. Murine models ofChlamydia pneumoniae infection and atherosclerosis. J. Infect. Dis. 175 (1997) 883–890.
Hyman, C. L., Roblin, P. M., Gaydos, C. A., Quinn, T. C., Schachter, J., Hammerschlag, M. R. The prevalence of asymptomatic nasopharyngeal carriage ofChlamydia pneumoniae in subjectively healthy adults. Assessment by polymerase chain reaction-enzyme immunoassay and culture. Clin. Infect. Dis. 20 (1995) 1174–1178.
Saikku, P. ChronicChlamydia pneumoniae infections. In:Allegra, L., Blasi, F. (eds.):Chlamydia pneumoniae infection. Springer Verlag, Milano 1995, pp. 51–64.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Stille, W., Dittmann, R. & Just-Nübling, G. Atherosclerosis due to chronic arteritis caused byChlamydia pneumoniae: A tentative hypothesis. Infection 25, 281–285 (1997). https://doi.org/10.1007/BF01720397
Issue Date:
DOI: https://doi.org/10.1007/BF01720397